Three labels, three answers
The US label for Rybelsus®, shared with Ozempic® tablets, builds its main table from reactions seen in at least 5% of people and more often than on placebo, then lists a few smaller stomach reactions [1]. Fatigue did not meet either test and does not appear in the postmarketing list either. Canada’s monograph uses the same two trials but sets the bar at 1%, so tiredness shows up there [3].
| Document | Fatigue entry | Placebo or comparison |
|---|---|---|
| Canadian Product Monograph, Table 3 [3] | 7 mg 3.7%, 14 mg 2.8% (PIONEER 1 and PIONEER 8) | Placebo 0% |
| EU summary of product characteristics, section 4.8 [2] | General disorders: common | 1 in 100 to 1 in 10 |
| EU and Canadian patient leaflets [2][3] | “Tiredness” among common side effects | Plain-language list |
| US Prescribing Information [1] | Not listed | Table 2 requires at least 5% |
What the small numbers can and cannot tell you
With 356 people per tablet strength, 3.7% means roughly 13 people on 7 mg, and 2.8% about 10 people on 14 mg, against none of the 362 on placebo [3]. That is a clear difference from placebo, but not a dose pattern: the higher strength did not bring more fatigue. The tables give no information on when tiredness began, how long it lasted or how severe it was.
The trials were in adults with type 2 diabetes, with an average age of 58 [1]. MedlinePlus lists diabetes itself among illnesses that can cause fatigue [5], which is one reason a placebo comparison matters so much for this symptom.
Outside trials, a 2024 analysis of US adverse-event reports and online patient reviews for semaglutide in both forms found fatigue was the fourth most mentioned problem in the reviews, with 104 mentions, and appeared in 737 database reports [4]. Self-selected reviews and voluntary reports cannot show how often fatigue happens or prove it was caused by the medicine.
Label warnings that can feel like exhaustion
- Low blood sugar: Rybelsus® with insulin or a sulfonylurea raises the risk of hypoglycaemia, including severe episodes [1]. The Medication Guide lists weakness, drowsiness, confusion, sweating and shakiness among possible signs [1]. MedlinePlus adds tiredness and trouble sleeping to its list [6].
- Fluid loss: nausea, vomiting and diarrhoea can lead to dehydration and kidney problems, and the Medication Guide asks you to drink fluids and to tell your provider right away if these symptoms do not go away [1]. Cleveland Clinic names dehydration as a cause of fatigue [7].
- Eating less: decreased appetite was reported by 5.9% on 7 mg and 9.0% on 14 mg, against 0.8% on placebo [3]. The documents do not study whether eating less explains tiredness, so this link is plausible but unmeasured.
Other causes worth ruling out
MedlinePlus and Cleveland Clinic list many causes unrelated to semaglutide [5][7]:
- Anaemia, iron deficiency and other vitamin shortfalls such as vitamin B12 or D.
- An underactive or overactive thyroid.
- Sleep disorders, including insomnia and obstructive sleep apnoea.
- Depression, grief and ongoing stress.
- Other medicines, such as sedatives, some antidepressants, antihistamines, blood pressure medicines and water pills.
- Infections, and long-term conditions such as kidney, liver or heart disease.
What general sources suggest
MedlinePlus suggests enough sleep, a balanced diet, drinking water through the day, regular exercise, a reasonable schedule, ways to relax, and avoiding alcohol and nicotine [5]. It notes that stimulants, including caffeine, do not treat fatigue and can make it worse when stopped, and that you should not stop or change a medicine without talking to your provider.
Cleveland Clinic adds keeping regular bed and wake times and avoiding caffeine, screens and exercise right before bed [7]. If a medicine seems to be wearing you out, it suggests discussing the risks and benefits of any change with your provider rather than deciding alone.
Points specific to the tablet
Rybelsus® is taken once a day, first thing in the morning, with a sip of plain water and at least 30 minutes before food, drink or other tablets [1]. That makes the morning a natural time to rate your energy, before breakfast or caffeine can colour the answer.
The usual US schedule starts at 3 mg for 30 days, then 7 mg, with 14 mg as an option from day 61 [1]. Because the Canadian table shows fatigue on both 7 mg and 14 mg, noting when tiredness began compared with these steps helps your prescriber judge whether the tablet is a likely cause.
Rybelsus® and Ozempic® are registered trademarks of Novo Nordisk A/S. PepLabo is not affiliated with or endorsed by Novo Nordisk.
When to get help
The signs and contact information below come from this article’s sourced guidance.
Emergency
Today
- Tiredness with confusion, dizziness, blurred vision or very little urine
Contact: Your provider right away
MedlinePlus [5]
- Nausea, vomiting or diarrhoea that does not go away
Contact: Your prescriber, right away
Rybelsus® Medication Guide [1]
- Weakness or drowsiness with sweating, hunger or shakiness
Contact: Treat low blood sugar as you were taught, then call your prescriber
Rybelsus® Medication Guide [1]